Haisco Pharmaceutical Expects to Double H1 Profit on Product Growth, Subsidies; Shares Up 4%

Published on 07/12/2024 at 02:12 - Modified on 07/12/2024 at 02:13

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Receives US FDA Approval for Autoimmune Drug Trials	Jul. 16	MT
Haisco Pharmaceutical to Raise 1.37 Billion Yuan via Share Placement; Shares Slump 5%	Jul. 07	MT
Haisco Pharmaceutical Gets Clinical Trial Nod for Muscle Dystrophy Drug	Jul. 02	MT
Haisco Pharmaceutical Group Gets Acceptance Notice for New Indication for HSK47388	Jun. 24	MT
Chinese Drug Regulator Accepts Haisco Pharmaceutical's Application for Autoimmune Drug's Trial	Jun. 03	MT
Intech Biopharm Ltd. Signs Supplemental Agreement for the SYN010 Product with Haisco Pharmaceutical Group	May. 06	CI
Declaration of Voting Results by Haisco Pharmaceutical Group	May. 06	CI
Haisco Pharmaceutical Group Co Receives a Proposal from Wang Junmin	Apr. 24	CI
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	Apr. 24	CI
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	Apr. 11	CI
Haisco Pharmaceutical Group Clarifies No Financial Assistance in Share Issuance	Mar. 03	MT
Haisco Pharmaceutical Group Co., Ltd. announced that it expects to receive CNY 1.3652567 billion in funding	Feb. 26	CI
Haisco Pharma's Unit Gets Nod to Trial HSK39004 Inhalation Powder	Feb. 06	MT
Haisco Pharma Plans To Set Up Subsidiary In U.S. For Business Development	Feb. 05	RE
Chinese Drug Regulator Accepts Haisco Pharma Unit's Application for Advanced Tumor Drug	Jan. 17	MT
Declaration of Voting Results by Haisco Pharmaceutica	Jan. 14	CI
Haisco Pharmaceutica Receives a Shareholder Proposal from Wang Junmin	Jan. 05	CI
Haisco Pharmaceutical, Unit Get Government Grants of 44 Million Yuan	Dec. 19	MT
Haisco Pharmaceutical Group Unit Gets Chinese Regulator's Nod for Prostrate Cancer Drug Clinical Trials	Dec. 05	MT
Haisco Pharmaceutical Group Sees Inclusion of Two Drugs in National Medical Insurance Catalog	Nov. 29	MT
Haisco Pharmaceutical Gets China Nod for Respiratory Drug	Nov. 07	MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-29	CI
Haisco Pharmaceutical to Set Up Subsidiaries in British Virgin Islands, Cayman Islands	24-09-20	MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-15	CI
Haisco Pharmaceutical's Unit to Carry Out Trials on Lung Disease Drug	24-08-08	MT